Abstract
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a recurrence of heart failure occurred after rechallenge with the therapy. (Level of Difficulty: Advanced.)
| Original language | English |
|---|---|
| Pages (from-to) | 1018-1023 |
| Number of pages | 6 |
| Journal | JACC: Case Reports |
| Volume | 3 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 7 2021 |
Bibliographical note
Publisher Copyright:© 2021 The Authors
Funding
This work was supported by American Heart Association (grant #18CDA34110361; LAB, 2018). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
| Funders | Funder number |
|---|---|
| American the American Heart Association | 18CDA34110361 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- MR sequences
- acute heart failure
- cancer
- cardiomyopathy
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver